These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 10342561)

  • 21. The complex interactions of p53 with target DNA: we learn as we go.
    Kim E; Deppert W
    Biochem Cell Biol; 2003 Jun; 81(3):141-50. PubMed ID: 12897847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-affinity binding of tumor-suppressor protein p53 and HMGB1 to hemicatenated DNA loops.
    Stros M; Muselíková-Polanská E; Pospísilová S; Strauss F
    Biochemistry; 2004 Jun; 43(22):7215-25. PubMed ID: 15170359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reactivation of mutant p53: molecular mechanisms and therapeutic potential.
    Selivanova G; Wiman KG
    Oncogene; 2007 Apr; 26(15):2243-54. PubMed ID: 17401433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Restoring wild-type conformation and DNA-binding activity of mutant p53 is insufficient for restoration of transcriptional activity.
    Brazda V; Muller P; Brozkova K; Vojtesek B
    Biochem Biophys Res Commun; 2006 Dec; 351(2):499-506. PubMed ID: 17070499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigating the interaction between oncogene and tumor suppressor protein.
    Pirogova E; Akay M; Cosic I
    IEEE Trans Inf Technol Biomed; 2009 Jan; 13(1):10-5. PubMed ID: 19129019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA binding and selective gene induction by different forms of the p53 protein.
    Mayelzadeh F; Martinez JD
    Oncogene; 2007 May; 26(21):2955-63. PubMed ID: 17130840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Twenty years of p53 research: structural and functional aspects of the p53 protein.
    May P; May E
    Oncogene; 1999 Dec; 18(53):7621-36. PubMed ID: 10618702
    [No Abstract]   [Full Text] [Related]  

  • 28. Mutant p53: "gain of function" through perturbation of nuclear structure and function?
    Deppert W; Göhler T; Koga H; Kim E
    J Cell Biochem Suppl; 2000; Suppl 35():115-22. PubMed ID: 11389540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure, function, and aggregation of the zinc-free form of the p53 DNA binding domain.
    Butler JS; Loh SN
    Biochemistry; 2003 Mar; 42(8):2396-403. PubMed ID: 12600206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The N-terminal domain of tumor suppressor p53 is involved in the molecular interaction with the anti-apoptotic protein Bcl-Xl.
    Xu H; Tai J; Ye H; Kang CB; Yoon HS
    Biochem Biophys Res Commun; 2006 Mar; 341(4):938-44. PubMed ID: 16455050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Docking study and free energy simulation of the complex between p53 DNA-binding domain and azurin.
    De Grandis V; Bizzarri AR; Cannistraro S
    J Mol Recognit; 2007; 20(4):215-26. PubMed ID: 17703463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CRINEPT-TROSY NMR reveals p53 core domain bound in an unfolded form to the chaperone Hsp90.
    Rudiger S; Freund SM; Veprintsev DB; Fersht AR
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11085-90. PubMed ID: 12163643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 9-Hydroxyellipticine alters the conformation and DNA binding characteristics of mutated p53 protein.
    Sugikawa E; Tsunoda S; Nakanishi N; Ohashi M
    Anticancer Res; 2001; 21(4A):2671-5. PubMed ID: 11724337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship among p53 oligomer formation, structure and transcriptional activity using a comprehensive missense mutation library.
    Kawaguchi T; Kato S; Otsuka K; Watanabe G; Kumabe T; Tominaga T; Yoshimoto T; Ishioka C
    Oncogene; 2005 Oct; 24(46):6976-81. PubMed ID: 16007150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrating mutation data and structural analysis of the TP53 tumor-suppressor protein.
    Martin AC; Facchiano AM; Cuff AL; Hernandez-Boussard T; Olivier M; Hainaut P; Thornton JM
    Hum Mutat; 2002 Feb; 19(2):149-64. PubMed ID: 11793474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oligomerization of p53 upon cooperative DNA binding: towards a structural understanding of p53 function.
    Chene P; Jahnke W
    Angew Chem Int Ed Engl; 2002 May; 41(10):1702-4. PubMed ID: 19750689
    [No Abstract]   [Full Text] [Related]  

  • 37. Probing the conformational diversity of cancer-associated mutations in p53 with ion-mobility mass spectrometry.
    Jurneczko E; Cruickshank F; Porrini M; Clarke DJ; Campuzano ID; Morris M; Nikolova PV; Barran PE
    Angew Chem Int Ed Engl; 2013 Apr; 52(16):4370-4. PubMed ID: 23494921
    [No Abstract]   [Full Text] [Related]  

  • 38. Four p(53)s in a pod.
    Chitayat S; Arrowsmith CH
    Nat Struct Mol Biol; 2010 Apr; 17(4):390-1. PubMed ID: 20368720
    [No Abstract]   [Full Text] [Related]  

  • 39. Flexibility: the key to p53 function?
    Milner J
    Trends Biochem Sci; 1995 Feb; 20(2):49-51. PubMed ID: 7701559
    [No Abstract]   [Full Text] [Related]  

  • 40. Ironing out the angles in p53.
    Nat Struct Biol; 1995 Apr; 2(4):253-4. PubMed ID: 7796256
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.